Skip to main content
Your browser does not support the audio tag.
  • Important Safety Information
  • Prescribing Information
  • Healthcare Professionals
  • Stay Connected
For Eczema For Plaque Psoriasis
vtama (tapinarof) cream 1%
  • Plaque Psoriasis Relief
  • Get Started on VTAMA cream
  • What Is Plaque Psoriasis?
  • Savings & Resources
  • Stay Connected
  • For Eczema
  • Resources
  • Derm Discussion Guide
  • FAQs
facebook      youtube
FDA-approved to treat adults with plaque psoriasis. See the results.

What is plaque psoriasis?

Plaque psoriasis is a chronic skin condition that causes patches of raised, inflamed, and red skin with silvery scales.
In skin of color, plaques may be thicker, have more scales, and appear like darker areas of skin.

It’s caused by an imbalance in your immune system that disrupts the normal function of cells in your skin.

Psoriasis plaques can affect any area of skin (this includes skin in sensitive areas like your face and neck, armpits, chest/breasts, groin, and genitals)*. The most common areas affected by psoriasis plaques include the knees and elbows, stomach, lower back, and scalp.

*Do not use VTAMA cream in your eyes, mouth, or vagina.
Plaque Psoriasis Impact
Talk to Your Dermatologist

Plaque psoriasis has a major impact on people everywhere

7.5 million adults

In the United States, there are over 7.5 million adults 20 years or older who have plaque psoriasis.

Plaque psoriasis is one of the most common diseases

Plaque psoriasis is one of the most common diseases affecting the immune system in the United States—which means there are so many people out there who know what it’s like to hide their skin under sleeves.

Plaque psoriasis affects men and women equally

Plaque psoriasis affects men and women equally. While race and/or ethnicity appears to have an impact on prevalence, White patients are 2 times as likely to have plaque psoriasis compared with non-White patients.

The effects of plaque psoriasis are more than just skin deep

Adults with plaque psoriasis report that it isn’t only itchy skin that disrupts their lives. They also report that their plaque psoriasis affects their overall well-being, and it interferes with their enjoyment of life.

The impact on quality of life differs between diverse ethnic groups. Plaque psoriasis has been associated with a greater negative impact on quality of life in non-White people compared with White people.

Plaque psoriasis has also been linked to non-skin-related problems. Conditions such as arthritis, diabetes, and hypertension have all been found to be linked to plaque psoriasis.

Not an actual patient.

Touch Deprivation and Plaque Psoriasis

In two large surveys†, one including 800 adults with plaque psoriasis and one including 800 adult family members of patients with plaque psoriasis, results showed that there is an emotional impact from touch deprivation which affects both patients and their family members:



7.5 million adults

of adult patients with plaque psoriasis felt deprived of physical touch from others because of their plaque psoriasis. 

Plaque psoriasis is one of the most common diseases

of partners of adult patients with plaque psoriasis surveyed revealed that plaque psoriasis has negatively impacted their relationships. 

Plaque psoriasis affects men and women equally

of adult patients with plaque psoriasis reported that they feel uncomfortable engaging in physical intimacy with a partner. 

Want to learn more about the Plaque Psoriasis Touch Deprivation Survey?

Download Key Findings


† KRC Research conducted the Psoriasis Touch survey using online surveys of n=800 U.S. adult patients with plaque psoriasis and n=800 U.S. adult family members of patients with plaque psoriasis. Surveys were fielded between July 14 - August 1, 2023.

Talk to your dermatologist

Can’t stop thinking about the possibility of clearer skin? Start your journey here.

This guide will help you and your dermatologist find the treatment that is right for you.

Let's Get Started

Download Blank Discussion Guide

Thank you for taking the assessment.

We hope this helps you on your journey to find a new treatment that is right for you. This may act as an easy and simple way to discuss things further with your dermatologist. Talk to your dermatologist to see if VTAMA cream may be right for you.

Get your guide!

Would you like to sign up for email updates?

     

Send Guide to Email

Print/Download Guide

Send Guide to Email

Print/Download Guide



IMPORTANT SAFETY INFORMATION

Indications: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for:

  • the topical treatment of plaque psoriasis in adults.
  • the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older.

Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).

Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Prescribing and Patient Information for VTAMA cream and discuss it with your doctor.

Dermavant
Sitemap
Contact Dermavant
Privacy Policy
Terms of Use
Cookies Settings

For assistance, call 1-8-DERMAVANT / 1-833-762-8268 Monday through Friday, 8:00 AM – 8:00 PM ET.

© 2023 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH. US-VTAMA-2300230

This website is intended for US audiences only. Information on this website is not intended as medical advice. Talk to your doctor about medical concerns.

facebook      youtube
Stay in the loop

Sign up today to get the latest around plaque psoriasis, VTAMA (tapinarof) cream, 1%, and other helpful tips and information.

*Required field

Please enter a first name
Please enter a last name
Please enter a valid ZIP code
Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

Thanks for signing up! Before you go…

Would you mind answering some additional questions for us?

This will help us tailor your VTAMA cream experience specifically to you!


1. What best describes your plaque psoriasis treatment journey?











2. Are you currently using VTAMA cream?











3. How involved are you in treatment decisions related to your plaque psoriasis?











*Required field

Please enter a first name
Please enter a last name
Please enter a valid ZIP code
Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

Please enter a first name
Please enter a last name
Please enter a valid ZIP code
Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

Please enter a first name
Please enter a last name
Please enter a valid ZIP code
Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

Please enter a valid email

By submitting this form, I agree to the Privacy Policy and Terms of Use.

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Manage Consent Preferences
pink plus sign Strictly Necessary Cookies
Always active
pink plus sign Performance Cookies
pink plus sign Targeting Cookies
Individual patient results:
You are now leaving this site
Click Continue below to leave the current site and be taken to a site maintained by a third party who is solely responsible for its content. Dermavant is providing this link to you only as a convenience; its inclusion does not imply the endorsement of the linked site by Dermavant.
Did you find what you were looking for?

Make sure to sign up for more education on plaque psoriasis and VTAMA cream before you leave the site.

Are you sure?
The contents of this site are intended for US Healthcare Professionals (HCP). Please certify that you are an HCP by clicking the appropriate link below.
You’re on your way

Thank you for signing up. You’ll be hearing from us soon.

Have more questions? Chat live with a nurse.

Email sent!
PopHeader ×
Popup
PopFooter

VTAMA® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

No thanks, take me to the VTAMA cream website
for adults with plaque psoriasis

US-VTMA-2400316

VTAMA® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

No thanks, take me to the VTAMA
cream website for adults with plaque psoriasis

IMPORTANT SAFETY INFORMATION
Indications: VTAMA® (tapinarof) cream, 1% is an aryl hydrocarbon receptor agonist indicated for:

  • the topical treatment of plaque psoriasis in adults.
  • the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older.

Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).

Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Nurse Chat